1 results found

Weijia Zhang, Jingyi Chen

Background: The objective of Phase I/II dose-finding design is to determine the Optimal Biological Dose(OBD) that is acceptably safe and demonstrates sufficient anti-tumor activity by maximizing a pre...

BMC Medical Research Methodology 2026-04-21 rs-8852216
Utility Adaptive penalties Toxicity-efficacy Dose-optimization trial
Back to Top
Home
Browse
Submit
About
0.037049s